妊娠糖尿病后产后葡萄糖不耐受:根据数据驱动的集群和BMI类别进行量身定制的预测
Anna Lesniara-Stachon1, Emmanuel Cosson2,3, Alain Lacroix4
1Obstetric Service, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Frontiers in endocrinology
|July 31, 2024
概括
妊娠糖尿病 (GDM) 的异质性意味着量身定制的风险评估是关键. 识别"胰岛素抵抗性"和"胰岛素缺乏"群体可以预测GDM女性未来的葡萄糖不耐受性 (GI).
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 生殖健康 生殖健康
背景情况:
- 孕期糖尿病 (GDM) 呈现出显著的异质性.
- 了解产后葡萄糖不耐受 (GI) 的预测因素对于长期的母亲健康至关重要.
- 现有的分类可能无法完全捕捉到GDM的多样性.
研究的目的:
- 在患有GDM的妇女中确定1年产后葡萄糖不耐受 (GI) 的量身定制预测因子.
- 根据数据驱动的集群和BMI类别来调查这些预测因素.
- 为GDM管理提供个性化风险评估策略的信息.
主要方法:
- 参与了179名患有GDM的女性的MySweetheart试验的二次分析.
- 使用集群分析 (年龄,BMI,HOMA-IR,HOMA-B) 和BMI类别 (正常体重,超重/肥胖) 评估的一年产后GI的预测因素.
- 在产后1年进行了口服葡萄糖耐受性测试和HbA1c测量.
主要成果:
- 确定了两个不同的群体:"胰岛素抵抗性"和"胰岛素缺乏".
- "胰岛素耐药"群体显示,产后肠道肠道疾病的风险显著增加 (2.9-3.5倍).
- 预测因群体和BMI类别而异,包括有史以来的GDM,禁食葡萄糖,HOMA-IR和产后胰岛素分泌指数.
结论:
- 患有GDM的女性可以分为"胰岛素抵抗性"和"胰岛素缺乏"群体,具有不同的未来肠道疾病风险.
- 胃肠道的预测因素依赖于集群和BMI,强调了个性化风险评估的必要性.
- 量身定制的方法对于有效的GDM跟踪和预防2型糖尿病至关重要.
相关概念视频
Pathophysiology of Diabetes
913
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
913
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229
Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K


